A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.

ABSTRACT:

Aim

The aim was to examine the impact of fee-for-service pharmacist-led medication review on patient outcomes and quantify this according to the type of review undertaken, e.g. adherence support and clinical medication review.

Methods

Relevant published studies were identified from Medline, Embase and International Pharmaceutical Abstract databases (from inception to February 2011). Study inclusion criteria were fee-for-service medication review, presence of a control group and pre-specified patient outcomes. Outcomes were grouped into primary (changes in biomarkers, hospitalization, and mortality) and secondary outcomes (medication adherence, economic implications and quality of life). Meta-analyses for primary outcomes were conducted using random effects models and seconda

SUBMITTER: Hatah E 

PROVIDER: S-EPMC3895351 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature